- Carnival Corporation will sell a total of 13 ships this year.
- It seeks to cut capacity in the wake of the Covid-19 outbreak.
- It has now more than doubled the number as it pans its phased re-entry to the market.
- These agreements are in addition to the sale of four ships.
- The company expects later deliveries of ships originally scheduled for fiscal 2022 and 2023.
- The cruise industry is trying to overhaul safety protocols to win back passengers’ trust
According to an article published in The Wall Street Journal and authored by Dave Sebastian, Carnival Corporation will sell a total of 13 ships this year as the cruise giant seeks to cut capacity in the wake of the Covid-19 outbreak.
Plans to dispose of ships
The company had previously confirmed plans to dispose of six ships but has now more than doubled the number as it pans its phased re-entry to the market.
The company sold one ship during June and has agreements for the disposal of five ships and preliminary agreements for an additional three ships, all of which are expected to leave the fleet in the next 90 days.
These agreements are in addition to the sale of four ships, which were announced prior to fiscal 2020.
Late delivery of ships
In total, the 13 ships expected to leave the fleet represent a nearly nine percent reduction in current capacity.
The company currently expects only five of the nine ships originally scheduled for delivery in fiscal 2020 and fiscal 2021 will be delivered prior to the end of the fiscal year 2021.
In addition, the company expects later deliveries of ships originally scheduled for fiscal 2022 and 2023.
Prolonged pause and right-sizing our shoreside operations
Carnival Corporation chief executive, Arnold Donald, noted: “We have been transitioning the fleet into a prolonged pause and right-sizing our shoreside operations. We have already reduced operating costs by over $7 billion on an annualized basis and reduced capital expenditures also by more than $5 billion over the next 18 months. We have secured over $10 billion of additional liquidity to sustain another full year with additional flexibility remaining. We have aggressively shed assets while actively deferring new ship deliveries.“
He said, “We are working hard to resume operations while serving the best interests of public health with our way forward informed through consultation with medical experts and scientists from around the world.”
Donald added: “We will emerge a leaner, more efficient company to optimize cash generation, pay down debt and position us to return to investment grade credit over time providing strong returns to our shareholders.”
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!
Source: TheWallStreetJournal
